Fernanda Costa dos Santos

Fernanda Costa dos Santos

Auto-generated profile, based on publicly available information

Fernanda Costa dos Santos

Hospital Nossa Senhora da Conceição and Hospital Cristo Redentor, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2022 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
MSMaira Viana Rego Souza-Silva
Maira Viana Rego Souza-Silva
PZPatricia Klarmann Ziegelmann
Patricia Klarmann Ziegelmann
VNVandack ALENCAR NOBRE Nobre
Vandack ALENCAR NOBRE Nobre
VGVirginia Mara Reis Gomes
Virginia Mara Reis Gomes
Ana Paula Beck da Silva EtgesAna Paula Beck da Silva Etges
Ana Paula Beck da Silva Etges
MMMilena Soriano Marcolino
Milena Soriano Marcolino

1 January 2022 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
VSVeridiana Baldon dos Santos
Veridiana Baldon dos Santos
ASAirton Tetelbom Stein
Airton Tetelbom Stein
SBSofia Louise Santin Barilli
Sofia Louise Santin Barilli
AGAndresa Fontoura Garbini
Andresa Fontoura Garbini
RARafaela Charão de Almeida
Rafaela Charão de Almeida
EWEstefania Inez Wittke
Estefania Inez Wittke
COVID-19 is a disease whose knowledge is still under construction, high transmissibility, with no consensual treatment available to everyone. Therefore, the identification of patients at higher risk of evolving to the critical form of the disease is fundamental. The study aimed to determine risk factors associated with the severity of COVID-19 in adults patients. This is an observational, retrospective study from a cohort of adult patients with COVID-19 admitted to a public hospital from March to August 2020, whose medical records were evaluated. For the association of possible severity predictors, a Poisson regression was used. The primary outcome was the critical form of the disease (need for admission to the Intensive Care Unit and/or invasive mechanical ventilation). We included 565 patients: mostly men; 55.5% of those who progressed to the critical form of the disease were over sixty years old. Hypertension, diabetes mellitus and obesity were the most frequent comorbidities. There were 39.8% of patients who progressed to the critical form of the disease. The hospital mortality rate was 22.1%, and that of critical patients was 46.7%. The independent factors associated with the severity of the disease were obesity [RR = 1.33 (95% CI 1.07 to 1.66; p = 0.011)], SpO2/FiO2 ratio ≤ 315 [RR = 2.20 (95% CI 1.79 to 2.71; p = 0.000)], C-reactive protein > 100 mg/L [RR = 1.65 (95% CI 1.33 to 2.06; p = 0.000)], and lymphocytes < 1,000/µL [RR = 1.44 (95% CI 1.18 to 1.75; p = 0.000)]. Advanced age and comorbidities were dependent factors strongly associated with the critical form of the disease.

28 December 2022 in Revista de Epidemiologia e Controle de Infecção
Verified
Journal Article
Open access
PDF file
RARafaela dos Santos Charão de Almeida
Rafaela dos Santos Charão de Almeida
AKAndré Klafke
André Klafke
AGAndresa Fontoura Garbini
Andresa Fontoura Garbini
DCDaniela dos Reis Carazai
Daniela dos Reis Carazai
FSFernanda Costa dos Santos
Fernanda Costa dos Santos
VBVeridiana Baldon
Veridiana Baldon
Background and objectives: COVID-19 is a life-threatening disease. Recognizing the main characteristics of the disease and its main complications will help future interventions, care, and management of health services since territorial and population diversities directly influence health outcomes. Our main objective is to describe the clinical characteristics, outcomes, and factors associated with mortality of patients with COVID-19 admitted to the intensive care unit of a public and tertiary hospital. Methods: Cohort study, conducted from March 1 to September 30, 2020. Poisson regression was performed to investigate the variables of hospital treatment as potential risk factors for in-hospital mortality. Results: Of the 283 eligible patients in this study, the hospital mortality rate was of 41.7% (n=118). The most common outcomes were acute respiratory distress syndrome, nosocomial infection, and septic shock. Factors independently associated with increased risk of death were age greater than 51 years old (RR=1.7, 95%CI=1.0-2.8), especially over 70 years old (RR=2.9, 95%CI=1.7-2.8), current smoker (RR=1.8, 95%CI=1.1-2.9), requiring the use of inotrope (RR=1.4, 95%CI=1.0-2.0), and presenting potassium greater than 5.0 mEq/l on admission (RR=1.3, 95%CI=1.0-1.7).

21 February 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDPolianna Delfino-Pereira
Polianna Delfino-Pereira
MPMagda Carvalho Pires
Magda Carvalho Pires
VGVirginia Mara Reis Gomes
Virginia Mara Reis Gomes
MNMatheus Carvalho Alves Nogueira
Matheus Carvalho Alves Nogueira
MLMaria Clara Pontello Barbosa Lima
Maria Clara Pontello Barbosa Lima
MMMilena Soriano Marcolino
Milena Soriano Marcolino
To analyze the clinical characteristics and outcomes of admitted patients with the hospital- versus community-manifested COVID-19 and to evaluate the risk factors related to mortality in the first population. This retrospective cohort included consecutive adult patients with COVID-19, hospitalized between March and September 2020. The demographic data, clinical characteristics, and outcomes were extracted from medical records. Patients with hospital-manifested COVID-19 (study group) and those with community-manifested COVID-19 (control group) were matched by the propensity score model. Logistic regression models were used to verify the risk factors for mortality in the study group. Among 7,710 hospitalized patients who had COVID-19, 7.2% developed symptoms while admitted for other reasons. Patients with hospital-manifested COVID-19 had a higher prevalence of cancer (19.2% vs 10.8%) and alcoholism (8.8% vs 2.8%) than patients with community-manifested COVID-19 and also had a higher rate of intensive care unit requirement (45.1% vs 35.2%), sepsis (23.8% vs 14.5%), and death (35.8% vs 22.5%) (P <0.05 for all). The factors independently associated with increased mortality in the study group were increasing age, male sex, number of comorbidities, and cancer. Hospital-manifested COVID-19 was associated with increased mortality. Increasing age, male sex, number of comorbidities, and cancer were independent predictors of mortality among those with hospital-manifested COVID-19 disease.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
PPPolianna Delfino Pereira
Polianna Delfino Pereira
MPMagda Carvalho Pires
Magda Carvalho Pires
VGVirginia Mara Reis Gomes
Virginia Mara Reis Gomes
MNMatheus Carvalho Alves Nogueira
Matheus Carvalho Alves Nogueira
MLMaria Clara Pontello Barbosa Lima
Maria Clara Pontello Barbosa Lima
MMMilena Soriano Marcolino
Milena Soriano Marcolino
Background: Some patients manifest COVID-19 symptoms while admitted for other reasons. Thus, we aimed to analyze clinical characteristics and outcomes of patients who developed COVID-19 symptoms during hospitalization when compared to those of patients hospitalized due to COVID-19; and to evaluate the risk factors related to mortality in the first population. Methods: This retrospective study included adult COVID-19 patients, hospitalized between March/2020 and September/2020. Demographic data, clinical characteristics and outcomes were extracted from medical records. Patients who manifested in-hospital COVID-19 (study group) and those who were admitted due to COVID-19 (control group) were matched by propensity score model. Logistic regression models were used to verify the risk factors for mortality, in the study group. Findings: Among 7,710 patients, 7·2% developed COVID-19 symptoms while admitted for other reasons. The most common causes of hospitalization were cardiovascular diseases (20·0%), and propaedeutics (19·5). The study group had a higher prevalence of alcoholism (8·8% vs. 2·8%), chronic renal disease (3·5% vs. 1·7%), and cancer (19·2% vs. 10·8%) when compared to controls (p<0·05 for all), as well as a higher rate of intensive care unit requirement (45·1% vs. 35·2%), sepsis (23·8% vs 14·5%), and death (35·8% vs. 22·5%), respectively (p<0·05 for all). The factors independently associated with increased mortality in the study group were increasing age, male sex, number of comorbidities and cancer. Interpretation: COVID-19 in-hospital manifestation was associated with worse outcomes. Older age, male sex, number of comorbidities, and cancer were independent risk factors for mortality. Funding Information: This study was supported in part by Minas Gerais State Agency for Research and Development (Fundação de Amparo à Pesquisa do Estado de Minas Gerais - FAPEMIG) [grant number APQ-01154-21], National Institute of Science and Technology for Health Technology Assessment (Instituto de Avaliação de Tecnologias em Saúde – IATS)/ National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq) [grant number 465518/2014-1], and CAPES Foundation (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) [grant number 88887.507149/2020-00]. Declaration of Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Ethics Approval Statement: The study protocol was approved by the National Commission for Research Ethics (CAAE: 30350820.5.1001.0008).